Thailand Breaks Merck's Patent For AIDS Drug
Efavirenz is used as part of antiretroviral therapy for the treatment of HIV-AIDs, usually in conjunction with other HIV-AIDS drugs. The Thai government already uses other off-patent drugs to treat AIDS patients, but as patients live longer and require more advanced therapies, drug costs have skyrocketed.
Thailand’s state-owned pharmaceutical manufacturer, the Government Pharmaceutical...
To view the full article, register now.